AstraZeneca-Amgen asthma drug hits 69% remission in esophageal disease trial - Reuters
AstraZeneca-Amgen asthma drug hits 69% remission in esophageal disease trial Reuters
Amgen Company News
TEZSPIRE® DELIVERED HISTOLOGIC REMISSION AND SYMPTOM IMPROVEMENT IN EOSINOPHILIC ESOPHAGITIS - Amgen
TEZSPIRE® DELIVERED HISTOLOGIC REMISSION AND SYMPTOM IMPROVEMENT IN EOSINOPHILIC ESOPHAGITIS Amgen
Amgen vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? - Yahoo Finance
Amgen vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? Yahoo Finance
Mattel appoints Amgen's Peter Griffith as CFO, succeeding Paul Ruh - Reuters
Mattel appoints Amgen's Peter Griffith as CFO, succeeding Paul Ruh Reuters
AMGEN TO PRESENT AT THE EUROPEAN SOCIETY OF MEDICAL ONCOLOGY CONGRESS 2026 - PR Newswire
AMGEN TO PRESENT AT THE EUROPEAN SOCIETY OF MEDICAL ONCOLOGY CONGRESS 2026 PR Newswire
Amgen vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Amgen vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? The Motley Fool
Amgen, AstraZeneca Detail Phase III Data For Tezspire’s Likely Third Indication - Scrip
Amgen, AstraZeneca Detail Phase III Data For Tezspire’s Likely Third Indication Scrip
Amgen Inc (AMGN) Shares Surge 3.3% -- What GF Score of 85 Tells Investors - GuruFocus
Amgen Inc (AMGN) Shares Surge 3.3% -- What GF Score of 85 Tells Investors GuruFocus
From Discovery to Delivery: 5 Ways Amgen Is Putting Sustainability into Practice - Amgen
From Discovery to Delivery: 5 Ways Amgen Is Putting Sustainability into Practice Amgen
Eli Lilly Rises 4% While Foundayo Nears European Approval; Amgen and Novo Nordisk Edge Higher - 24/7 Wall St.
Eli Lilly Rises 4% While Foundayo Nears European Approval; Amgen and Novo Nordisk Edge Higher 24/7 Wall St.
Amgen, AstraZeneca report phase 3 results for Tezspire in eosinophilic esophagitis - Seeking Alpha
Amgen, AstraZeneca report phase 3 results for Tezspire in eosinophilic esophagitis Seeking Alpha
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know Yahoo Finance
Amgen Inc. $AMGN Stock Bought by Sumitomo Mitsui DS Asset Management Company Ltd - MarketBeat
Amgen Inc. $AMGN Stock Bought by Sumitomo Mitsui DS Asset Management Company Ltd MarketBeat
AstraZeneca/Amgen Drug Shows Significant Remission in Eosinophilic Esophagitis Study - Benzinga
AstraZeneca/Amgen Drug Shows Significant Remission in Eosinophilic Esophagitis Study Benzinga
2 Dividend Stocks Crushing the Market in 2026 (and Which Ones Can Keep Going) - The Globe and Mail
2 Dividend Stocks Crushing the Market in 2026 (and Which Ones Can Keep Going) The Globe and Mail
Mattel Names Peter Griffith Chief Financial Officer, Replacing Paul Ruh - WSJ
Mattel Names Peter Griffith Chief Financial Officer, Replacing Paul Ruh WSJ
Amgen Has the Drugs and the Dividend. Now It Needs the Growth - Yahoo Finance
Amgen Has the Drugs and the Dividend. Now It Needs the Growth Yahoo Finance
Amgen (AMGN) and AstraZeneca Report Positive Phase 3 Trial Resul - GuruFocus
Amgen (AMGN) and AstraZeneca Report Positive Phase 3 Trial Resul GuruFocus
10,773 Amgen Inc. $AMGN Shares Sold by Novem Group - MarketBeat
10,773 Amgen Inc. $AMGN Shares Sold by Novem Group MarketBeat
Amgen Inc. $AMGN Stock Sold by First Bank & Trust - MarketBeat
Amgen Inc. $AMGN Stock Sold by First Bank & Trust MarketBeat
Amgen, AstraZeneca report positive trial results for Tezspire in EoE - Investing.com
Amgen, AstraZeneca report positive trial results for Tezspire in EoE Investing.com
2,560 Amgen Inc. $AMGN Shares Sold by Generali Investments Management Co LLC - MarketBeat
2,560 Amgen Inc. $AMGN Shares Sold by Generali Investments Management Co LLC MarketBeat
Amgen (AMGN) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
Amgen (AMGN) Exceeds Market Returns: Some Facts to Consider Yahoo Finance
Amgen Inc. $AMGN Position Lifted by IFP Advisors Inc - MarketBeat
Amgen Inc. $AMGN Position Lifted by IFP Advisors Inc MarketBeat
Greg Jennings LLC Buys New Position in Amgen Inc. $AMGN - MarketBeat
Greg Jennings LLC Buys New Position in Amgen Inc. $AMGN MarketBeat
Amgen Inc. $AMGN Stock Sold by TD Waterhouse Canada Inc. - MarketBeat
Amgen Inc. $AMGN Stock Sold by TD Waterhouse Canada Inc. MarketBeat
Amgen Inc. $AMGN Stock: Frank Rimerman Advisors LLC Raises Holdings - MarketBeat
Amgen Inc. $AMGN Stock: Frank Rimerman Advisors LLC Raises Holdings MarketBeat
Amgen/AstraZeneca unveil strong Ph III results for Tezspire in EoE - The Pharma Letter
Amgen/AstraZeneca unveil strong Ph III results for Tezspire in EoE The Pharma Letter
Amgen Inc. (NASDAQ:AMGN) Stock Has Average Price Target of $387.93 - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Stock Has Average Price Target of $387.93 MarketBeat
Amgen Inc. $AMGN Stock Purchased by New England Research & Management Inc. - MarketBeat
Amgen Inc. $AMGN Stock Purchased by New England Research & Management Inc. MarketBeat
Amgen Inc. $AMGN Shares Acquired by Annex Advisory Services LLC - MarketBeat
Amgen Inc. $AMGN Shares Acquired by Annex Advisory Services LLC MarketBeat
90,613 Amgen Inc. $AMGN Shares Sold by Fort Washington Investment Advisors Inc. OH - MarketBeat
90,613 Amgen Inc. $AMGN Shares Sold by Fort Washington Investment Advisors Inc. OH MarketBeat
Amgen Ranks #4 on Forbes’ Most Innovative Large Companies List - Amgen
Amgen Ranks #4 on Forbes’ Most Innovative Large Companies List Amgen
Amgen, Equifax among market cap stock movers on Tuesday - Investing.com
Amgen, Equifax among market cap stock movers on Tuesday Investing.com
Amgen's Q3 2026 Earnings: What to Expect - Barchart.com
Amgen's Q3 2026 Earnings: What to Expect Barchart.com
Amgen (NASDAQ:AMGN) Upgraded at Wall Street Zen - MarketBeat
Amgen (NASDAQ:AMGN) Upgraded at Wall Street Zen MarketBeat
Amgen Inc. $AMGN Stock Position Reduced by Milestone Asset Management LLC - MarketBeat
Amgen Inc. $AMGN Stock Position Reduced by Milestone Asset Management LLC MarketBeat
Amgen Inc. $AMGN Stock Holdings Cut by Curated Wealth Partners LLC - MarketBeat
Amgen Inc. $AMGN Stock Holdings Cut by Curated Wealth Partners LLC MarketBeat
Amgen Inc. $AMGN Stock Acquired by State of Alaska Department of Revenue - MarketBeat
Amgen Inc. $AMGN Stock Acquired by State of Alaska Department of Revenue MarketBeat
Amgen Inc. $AMGN Stock Sold by WealthPlan Investment Management LLC - MarketBeat
Amgen Inc. $AMGN Stock Sold by WealthPlan Investment Management LLC MarketBeat